Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
INNIO signs Definitive Agreement to Acquire Enerflex APAC Operations, Expanding Service Capabilities in the Asia-Pacific Region
-
Fanstanza Launches: A New Voice for Fans, Led by Veteran Editor Amanda Tan
-
Veolia Environnement: 2025, a Pivotal Year: Record Results Above Guidance
-
Oncoinvent ASA: Second half 2025 results
-
Sivers Semiconductors AB (publ), Publishes Interim Report Q4, October - December 2025
-
XCMG Drives National Standard for Crane Graphical Symbols, Strengthening Leadership in Industry Standardization
-
Allianz Achieves Record Operating Profit of 17.4 Billion Euros – Excellent Start to New Strategic Cycle
-
Singapore Tourism Board and Ant International Deepen Partnership to Accelerate Tourism Growth Through Travel Innovation
-
Technip Energies Full Year 2025 Financial Results
-
Bouygues: Very robust 2025 results and free cash flow at a record level
-
Azerion publishes Interim Unaudited Financial Results Q4 2025 and Preliminary Unaudited Financial Results Full Year 2025
-
TCM Group A/S: Annual Report 2025
-
Aalberts N.V.: Aalberts reports full year results 2025
-
Eurofins announces the publication of its 2025 Annual Report and 2025 Environmental, Social and Governance Report
-
Bekaert announces the next tranche of its Share Buyback Program
-
Stigmare Announces New Client Ballard Box Worx, a North Texas Builder of Container-Based Job Site Offices Engineered for Extreme Heat
-
Alm. Brand A/S - Annual Report 2025
-
XTransfer Receives Malaysia Central Bank's Conditional Approval for Key Payment Licences
-
Phonak ambassadors spotlight hearing health for the next generation on World Hearing Day
-
CMB.TECH ANNOUNCES Q4 2025 RESULTS - EIGHT VLCCS SOLD AT STELLAR PRICES
-
SBM Offshore Full Year 2025 Earnings
-
Getlink Announces a New Phase of Medium-Term Growth, and Targets €1 Billion EBITDA by 2030
-
WENDEL: 2025 Full-Year Results
-
Prosafe SE: Fourth-quarter results 2025
-
Getlink SE: Annual Results 2025: EBITDA at €859 Million, Above Guidance; Dividend of €0.80 Per Share¹
-
ARKEMA: Full-Year 2025 Results
-
Sopra Steria Group: 2025 Results
-
CTP N.V. FY-2025 Results
-
Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics
-
Adams Street Appoints Chris Cho to Lead Investor Relations in Asia
-
The National Museum of Modern Art, Tokyo, Offering English-language Collection Tour "Explore with Us"; Set to Present "Blossoms in Japanese Art: Spring Festival" in March
-
Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics
-
Syensqo fourth quarter and full year 2025 results
-
argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
-
Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results
-
Start of Day Message
-
Sequana Medical Reports Strong US Commercial Progress with Five Centers Completing alfapump® System Implants Since Launch
-
AS Tallinna Sadam unaudited financial results for the year 2025 and Q4
-
Idorsia reports strong 2025 results with QUVIVIQ sales more than doubling – further sales growth ahead with multiple pipeline catalysts in 2026
-
Corbion announces strong full-year 2025 results with +26.7% organic Adjusted EBITDA growth, +63.3% EPS growth, and €90.8 million in FCF; announces special dividend
-
Planisware: Strong 2025 performance with renewed commercial momentum at year-end
-
Full-year results 2025: record performance marks 150 years of delivery
-
Clariant delivers third year of strong EBITDA margin improvement – EBITDA margin before exceptional items up 180 basis points versus prior year to 17.8 %
-
Expansion of the elderly care home “Tartu Südamekodu” in Tartu County
-
Bekaert: 2025 Full Year Results
-
dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program
-
Faraday Future to Kick Off 2026 EAI Robotics Deliveries Beginning Feb. 27 by Delivering to an Airbnb Operator; Establishes First U.S. “EAI Robot & Vehicle + Vacation Rental” Deployment
-
THC Gummies: Budpop Ranked #1 by Sarasota Magazine for Premium THC Edibles
-
argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
-
Annual Results 2025: clear second half improvement, restructuring measures show first results
